Deborah Knobelman insider trades

Open-market stock purchases and sales by Deborah Knobelman, President & Interim CEO at Kronos Bio, Inc, from SEC Form 4 filings since Oct 3, 2022.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • KRON Kronos Bio, Inc: 1 sale, last Jun 20, 2025
  • SNTI Senti Biosciences, Inc: other filings, last Feb 1, 2024

Get free alerts when Deborah Knobelman files a new trade →